Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ohresser

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Critical Reviews in Oncology/Hematology|July 13, 2007
Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatmentCharlotte Magdelaine-Beuzelin, Quentin Kaas, Vanessa Wehbi, et al.
Bioanalysis|March 26, 2021
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrationsCéline Desvignes, David Ternant, Thierry Lecomte, et al.
The Journal of Urology|August 21, 2010
VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaFranck Bruyère, Christopher M Hovens, Marie-Noëlle Marson, et al.
Blood|November 26, 2008
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20David Daydé, David Ternant, Marc Ohresser, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2006
CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemiaFlorence Dommange, Guillaume Cartron, Claire Espanel, et al.
Mabs|June 12, 2013
Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodiesChristophe Passot, Nicolas Azzopardi, Sylvaine Renault, et al.
British Journal of Clinical Pharmacology|July 6, 2007
Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgammaRIIIa genetic polymorphismDavid Ternant, Matthias Büchler, Maud Bénéton, et al.
Pharmacogenetics and Genomics|December 14, 2005
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's diseaseStéphanie Willot, Severine Vermeire, Marc Ohresser, et al.
Pharmacogenetics and Genomics|March 26, 2009
IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximabCharlotte Magdelaine-Beuzelin, Séverine Vermeire, Margaret Goodall, et al.
Cell Communication and Signaling : CCS|July 10, 2026
P2X4 receptor limits adverse cardiac remodeling following ischemia-reperfusion through regulation of autophagy in cardiac fibroblastsAna Valeria Vinhais da Silva, Juliette Strella, Simon Chesseron, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Critical Reviews in Oncology/Hematology|July 13, 2007
Structure-function relationships of the variable domains of monoclonal antibodies approved for cancer treatmentCharlotte Magdelaine-Beuzelin, Quentin Kaas, Vanessa Wehbi, et al.
Bioanalysis|March 26, 2021
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrationsCéline Desvignes, David Ternant, Thierry Lecomte, et al.
The Journal of Urology|August 21, 2010
VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinomaFranck Bruyère, Christopher M Hovens, Marie-Noëlle Marson, et al.
Blood|November 26, 2008
Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20David Daydé, David Ternant, Marc Ohresser, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 5, 2006
CXCL12 polymorphism and malignant cell dissemination/tissue infiltration in acute myeloid leukemiaFlorence Dommange, Guillaume Cartron, Claire Espanel, et al.
Mabs|June 12, 2013
Influence of FCGRT gene polymorphisms on pharmacokinetics of therapeutic antibodiesChristophe Passot, Nicolas Azzopardi, Sylvaine Renault, et al.
British Journal of Clinical Pharmacology|July 6, 2007
Interindividual variability in the concentration-effect relationship of antilymphocyte globulins - a possible influence of FcgammaRIIIa genetic polymorphismDavid Ternant, Matthias Büchler, Maud Bénéton, et al.
Pharmacogenetics and Genomics|December 14, 2005
No association between C-reactive protein gene polymorphisms and decrease of C-reactive protein serum concentration after infliximab treatment in Crohn's diseaseStéphanie Willot, Severine Vermeire, Marc Ohresser, et al.
Pharmacogenetics and Genomics|March 26, 2009
IgG1 heavy chain-coding gene polymorphism (G1m allotypes) and development of antibodies-to-infliximabCharlotte Magdelaine-Beuzelin, Séverine Vermeire, Margaret Goodall, et al.
Cell Communication and Signaling : CCS|July 10, 2026
P2X4 receptor limits adverse cardiac remodeling following ischemia-reperfusion through regulation of autophagy in cardiac fibroblastsAna Valeria Vinhais da Silva, Juliette Strella, Simon Chesseron, et al.
Pageof 2